{{ $DoctorName }} @if (isset(session()->get('doctor')['vCentralCode'])) {{ session()->get('doctor')['vCentralCode'] }} @endif
@if (isset(session()->get('doctor')['vCentralCode']))
Logout
@endif

{{ $ActivityTypeName }}

{{ $ActivityName }}

@csrf
@if (isset(session()->get('doctor')['vCentralCode']))
Back
@else
@endif

Dermatologist based epidemiological survey in patients of dermatophytosis in India

Survey Questionnaire Form
Doctor’s details

Questionnaire

  1. What percentage of your patients visited for dermatophytosis condition? *

  2. What are the primary presenting complaints in dermatophytosis patients? (Multiple options can be selected) *

  3. Most common site of involvement in dermatophytosis patients? (Multiple options can be selected) *

  4. What percentage of your patients with dermatophytosis have comorbid conditions like hypertension, diabetes mellitus and obesity? *

  5. How many patients gave a history of receiving OTC steroid cream? *

  6. Initial diagnosis of fungal infection is based on: *

  7. Do you recommend fungal culture in your patients? *

  8. In which particular scenario do you recommend fungal culture in dermatophytosis patients? (Multiple options can be selected) *

  9. How do you treat a patient with fungal infection? (Multiple options can be selected) *

  10. Do you prescribe only topical antifungals to your patients *

  11. Minimum duration of treatment for naïve cases. *

  12. Minimum duration of treatment for recalcitrant cases. *

  13. Topical antifungal should be continued for how long period after clinical resolution? *

  14. Which topical antifungal is your preferred molecule? *

  15. Which systemic antifungal is your preferred molecule? *

  16. Does super bioavailable Itraconazole shows superior efficacy over conventional Itraconazole? *

  17. How many of your patients are compliant for the dermatophytosis treatment? *

  18. Do you prescribe any adjuvant medications like antihistamine, moisturizer in addition to antifungals (topical or systemic) to your patients? *